Epithelioid Mesothelioma
Also known as: Epithelioid mesothelioma, malignant (morphologic abnormality) / Epithelial malignant mesothelioma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11595 | Atezolizumab | 1 | Active Not Recruiting | 1 |
| DB14547 | Chloride ion | 1 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 1 | Active Not Recruiting | 1 |
| DB18591 | LMB-100 | 1 | Completed | 1 |
| DB00642 | Pemetrexed | 1 | Active Not Recruiting | 1 |
| DB12257 | Platinum | 1 | Active Not Recruiting | 1 |
| DB08895 | Tofacitinib | 1 | Completed | 1 |
| DB04849 | Cediranib | 1 / 2 | Active Not Recruiting | 1 |
| DB14547 | Chloride ion | 1 / 2 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 1 / 2 | Active Not Recruiting | 1 |
| DB00642 | Pemetrexed | 1 / 2 | Active Not Recruiting | 1 |
| DB12257 | Platinum | 1 / 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB06026 | Tivantinib | 2 | Terminated | 1 |
| DB12200 | Tivantinib | 2 | Terminated | 1 |